A report by The Health and Social Care Committee reveals that Omicron and the emergency care crisis could derail plans to tackle the backlog of people waiting to seek elective care.
The European Medicines Agency (EMA) has recommended that aducanumab, marketed as Aduhelm, is not approved for use across the EU. The drug was previously approved for use in the US by the Food and Drug Administration (FDA) on 7 June 2021.
NHS England announced today that a fifth (20.6%) - around 60,000 - of people in older adult care homes have still not received their COVID-19 booster vaccination.
NHS England's latest vaccination data released today (09/12/21) shows a quarter of people in care homes have still not received their COVID-19 booster vaccination, despite the government's promise for everyone to be offered the jab by 1 November 2021.